Autopsy report · NCT02171546
Relative Bioavailability of Dabigatran Etexilate Capsules With and Without Quinidine Sulfate Tablets and to Measure the Effect of Quinidine on the Absorption of Fexofenadine in Healthy Male and Female Volunteers
Cause of deathNo reason given
Life of this trial
- Registered 6 years 7 months after it had already started.
- 42 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Boehringer Ingelheim
- Sponsor type
- Industry
- Conditions
- Healthy
- Interventions
- Dabigatran etexilate capsules; Quinidine sulfate tablets; Fexofenadine tablets
- Participants
- 42
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.